Megan Baumgart
Impact in
-
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
- PARP inhibition in cancer therapy 2
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Scott Gettinger (2 shared papers)Mary W. Redman (2 shared papers)David R. Gandara (2 shared papers)Roy S. Herbst (3 shared papers)Karen Kelly (3 shared papers)James Moon (1 shared paper)Sarah B. Goldberg (1 shared paper)Rogério Lilenbaum (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer (1 paper)Translational Lung Cancer Research (1 paper)Biochemistry (1 paper)Clinical and Translational Science (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Megan Baumgart
17 papers receiving 155 citations
Peers
Comparison fields: 5 of 49
- Oncology 77
- Pulmonary and Respiratory Medicine 58
- Cancer Research 20
- Clinical Biochemistry 9
- Biochemistry 8
Countries citing papers authored by Megan Baumgart
This map shows the geographic impact of Megan Baumgart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Baumgart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Baumgart more than expected).
Fields of papers citing papers by Megan Baumgart
This network shows the impact of papers produced by Megan Baumgart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Baumgart. The network helps show where Megan Baumgart may publish in the future.
Co-authors
The 25 scholars most cited alongside Megan Baumgart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 52 | |
| 2 | 1999 | 49 | |
| 3 | 2015 | 11 | |
| 4 | 2021 | 8 | |
| 5 | 2020 | 7 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 2 | |
| 12 | 2016 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2020 | 1 |
About Megan Baumgart
Megan Baumgart is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Cellular and Molecular Neuroscience, having authored 17 papers that have together received 156 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), PARP inhibition in cancer therapy (2 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Palliative Care and End-of-Life Issues (2 papers). The work is most often cited by research in Oncology (77 citations), Pulmonary and Respiratory Medicine (58 citations), Cancer Research (20 citations), Clinical Biochemistry (9 citations) and Biochemistry (8 citations). Megan Baumgart has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Scott Gettinger, Mary W. Redman, David R. Gandara, Roy S. Herbst, Karen Kelly, James Moon, Sarah B. Goldberg, Rogério Lilenbaum, Katerina Politi and Mitchell A. deLong. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Translational Lung Cancer Research, Biochemistry and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.